Literature DB >> 21160701

Cardiovascular and metabolic effects of Berberine.

Flora Affuso1, Valentina Mercurio, Valeria Fazio, Serafino Fazio.   

Abstract

Berberine (BBR) is a natural alkaloid isolated from the Coptis Chinensis. While this plant has been used in Ayurvedic and Chinese medicine for more than 2500 years, interest in its effects in metabolic and cardiovascular disease has been growing in the Western world in the last decade. Many papers have been published in these years reporting beneficial effects in carbohydrate and lipid metabolism, endothelial function and the cardiovascular system. In this review, we report a detailed analysis of the scientific literature regarding this topic, describing the effects and the underlying mechanisms of BBR on carbohydrate and lipid metabolism, endothelial function and the cardiovascular system.

Entities:  

Keywords:  Adenosine monophosphate kinase; Berberine; Endothelial function; Hyperlipidemia; Insulin resistance; Metabolic syndrome

Year:  2010        PMID: 21160701      PMCID: PMC2999047          DOI: 10.4330/wjc.v2.i4.71

Source DB:  PubMed          Journal:  World J Cardiol


  50 in total

1.  The effect of AMP-activated protein kinase and its activator AICAR on the metabolism of human umbilical vein endothelial cells.

Authors:  Z Dagher; N Ruderman; K Tornheim; Y Ido
Journal:  Biochem Biophys Res Commun       Date:  1999-11       Impact factor: 3.575

2.  Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation.

Authors:  Yasuo Ido; David Carling; Neil Ruderman
Journal:  Diabetes       Date:  2002-01       Impact factor: 9.461

3.  The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways.

Authors:  Lee G D Fryer; Asha Parbu-Patel; David Carling
Journal:  J Biol Chem       Date:  2002-05-06       Impact factor: 5.157

4.  Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins.

Authors:  Weijia Kong; Jing Wei; Parveen Abidi; Meihong Lin; Satoru Inaba; Cong Li; Yanling Wang; Zizheng Wang; Shuyi Si; Huaining Pan; Shukui Wang; Jingdan Wu; Yue Wang; Zhuorong Li; Jingwen Liu; Jian-Dong Jiang
Journal:  Nat Med       Date:  2004-11-07       Impact factor: 53.440

5.  Berberine stimulates glucose transport through a mechanism distinct from insulin.

Authors:  Libin Zhou; Ying Yang; Xiao Wang; Shangquan Liu; Wenbin Shang; Guoyue Yuan; Fengying Li; Jinfeng Tang; Mingdao Chen; Jialun Chen
Journal:  Metabolism       Date:  2007-03       Impact factor: 8.694

6.  Insulin receptor substrate-1 and phosphoinositide-dependent kinase-1 are required for insulin-stimulated production of nitric oxide in endothelial cells.

Authors:  Monica Montagnani; Lingamanaidu V Ravichandran; Hui Chen; Diana L Esposito; Michael J Quon
Journal:  Mol Endocrinol       Date:  2002-08

7.  Berberine-induced decline in circulating CD31+/CD42- microparticles is associated with improvement of endothelial function in humans.

Authors:  Jie-mei Wang; Zhen Yang; Ming-guo Xu; Long Chen; Yan Wang; Chen Su; Jun Tao
Journal:  Eur J Pharmacol       Date:  2009-05-03       Impact factor: 4.432

Review 8.  Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase.

Authors:  D G Hardie; D A Pan
Journal:  Biochem Soc Trans       Date:  2002-11       Impact factor: 5.407

9.  Atorvastatin increases human serum levels of proprotein convertase subtilisin/kexin type 9.

Authors:  Holly E Careskey; R Aleks Davis; William E Alborn; Jason S Troutt; Guoqing Cao; Robert J Konrad
Journal:  J Lipid Res       Date:  2007-11-21       Impact factor: 5.922

10.  Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase.

Authors:  Yiqun Wang; Yu Huang; Karen S L Lam; Yiming Li; Wing Tak Wong; Hongying Ye; Chi-Wai Lau; Paul M Vanhoutte; Aimin Xu
Journal:  Cardiovasc Res       Date:  2009-02-27       Impact factor: 10.787

View more
  29 in total

1.  Insulin resistance: Is it time for primary prevention?

Authors:  Valentina Mercurio; Guido Carlomagno; Valeria Fazio; Serafino Fazio
Journal:  World J Cardiol       Date:  2012-01-26

Review 2.  Herbs Used for the Treatment of Hypertension and their Mechanism of Action.

Authors:  Steven G Chrysant; George S Chrysant
Journal:  Curr Hypertens Rep       Date:  2017-09-18       Impact factor: 5.369

Review 3.  Metformin and metabolic diseases: a focus on hepatic aspects.

Authors:  Juan Zheng; Shih-Lung Woo; Xiang Hu; Rachel Botchlett; Lulu Chen; Yuqing Huo; Chaodong Wu
Journal:  Front Med       Date:  2015-02-12       Impact factor: 4.592

4.  Alkaloids of Dicranostigma franchetianum (Papaveraceae) and Berberine Derivatives as a New Class of Antimycobacterial Agents.

Authors:  Viriyanata Wijaya; Ondřej Janďourek; Jana Křoustková; Kateřina Hradiská-Breiterová; Jan Korábečný; Kateřina Sobolová; Eliška Kohelová; Anna Hošťálková; Klára Konečná; Marcela Šafratová; Rudolf Vrabec; Jiří Kuneš; Lubomír Opletal; Jakub Chlebek; Lucie Cahlíková
Journal:  Biomolecules       Date:  2022-06-17

5.  Myocardial Salvaging Effects of Berberine in Experimental Diabetes Co-Existing with Myocardial Infarction.

Authors:  Rajesh Kumar Suman; Manjusha K Borde; Ipseeta Ray Mohanty; Ujwala Maheshwari; Y A Deshmukh
Journal:  J Clin Diagn Res       Date:  2016-03-01

6.  Berberine-Promoted CXCR4 Expression Accelerates Endothelial Repair Capacity of Early Endothelial Progenitor Cells in Persons with Prehypertension.

Authors:  Yi-Jia Shao; Jun Tao; Bing-Bo Yu; Dan Meng; Xu-Long Yang; Jia-Pan Sun; Yan-Xia Qiu; Xiao-Yu Zhang
Journal:  Chin J Integr Med       Date:  2018-10-19       Impact factor: 1.978

7.  Cardioprotective effect of berberine against myocardial ischemia/reperfusion injury via attenuating mitochondrial dysfunction and apoptosis.

Authors:  Yongjun Wang; Jianzhen Liu; Airui Ma; Yanqiang Chen
Journal:  Int J Clin Exp Med       Date:  2015-08-15

8.  Berberine Attenuates Neonatal Sepsis in Mice By Inhibiting FOXA1 and NF-κB Signal Transduction Via the Induction of MiR-132-3p.

Authors:  Binghui Li; Shiping Niu; Hongli Geng; Changkun Yang; Changliang Zhao
Journal:  Inflammation       Date:  2021-09-14       Impact factor: 4.092

Review 9.  Potential benefits of berberine in the management of perimenopausal syndrome.

Authors:  Cristiana Caliceti; Paola Rizzo; Arrigo Francesco Giuseppe Cicero
Journal:  Oxid Med Cell Longev       Date:  2015-02-17       Impact factor: 6.543

10.  Berberine via suppression of transient receptor potential vanilloid 4 channel improves vascular stiffness in mice.

Authors:  Jie Wang; Tao Guo; Qi-Sheng Peng; Shou-Wei Yue; Shuang-Xi Wang
Journal:  J Cell Mol Med       Date:  2015-07-14       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.